Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.

Illumina Ventures

OMX Ventures

ARCH Venture Partners

Longwall Venture Partners

M Ventures

+ND Capital

Lightcast

Microsoft Exchange Online

Office 365 Mail

Microsoft Azure DNS

GoDaddy DNS

Atlassian Cloud

Namecheap Hosting

Head of Engineering

James Lazarus

Business Management

Kathrin Herbst

Marketing and Product

Scott Brouilette

Sales and Support

Simon Margerison

Tom Isaac

Software Development Manager

Emma Armstrong

Engineering

Claire Murzeau

Operations

Craig Tombling

Drew Geere

Human Resources

Frances Derd

Paul Loeffen

Chief Executive Officer

Europe, Middle East, and Africa (EMEA) Companies With Less Than $500M in Revenue (Top 10K)

Europe Companies (Top 10K)

Europe Early Stage Companies With Less Than $1B in Revenue

Europe, Middle East, and Africa (EMEA) Early Stage Companies With Less Than $1B in Revenue

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

The company's mission is to push the boundaries of complex cell analysis. Using the Lightcast platform, the company is working with major pharmaceutical companies and leading academic institutes to enable them to discover more. The Lightcast platform allows precise and highly flexible independent control of thousands of droplets. By combining droplets containing different cells, reporters or other reagents we can perform complex workflows without the need to manipulate cells by hand.

Lightcast Discovery was founded in 2019 by Cameron Frayling.

Series B - Lightcast Discovery

Seed Round - Lightcast Discovery

Computer and Software Products and Electrical and Scientific Products

Cambridge

Cambridgeshire

United Kingdom

Europe

Lightcast Discovery

US healthcare heavyweights help launch Lightcast SAB

Lightcast Announces Scientific Advisory Board

Lightcast Opens Innovation Center in United States to Support Global Expansion of Luminary Early Access Program

XREAL competitor Rokid closes $112M Series C to scale AR ...

Immaterial cleans up with Series A cash to build ...

The biggest private biotech investments in August 2023

Empowering research: Lightcast Discovery secures $49M to unveil Single-Cell functional analysis platform — TFN

A droplet-based microfluidics and optical electrowetting-on-dielectric (oEWOD) platform for single-cell assays.

Enables massively parallel and sequential single-cell assays for functional analysis.

Facilitates the recovery of live cells for downstream applications such as clonal outgrowth or NGS-based readouts.

Streamlines the lead identification and optimization stage with multi-step, single-cell assays.

Supports studies on cell-to-cell communication, immune function, and CRISPR edits impact on a single platform.

Italy

India

Asia

Canada

North America

SeekOut is a competitor that offers AI-driven talent search and recruitment solutions.

SeekOut

Dayforce is a competitor that provides cloud-based human capital management solutions.

Dayforce

Phenom is a competitor specializing in talent experience management solutions.

Phenom

VaxCare is a competitor in the biotechnology sector, focusing on vaccine management solutions.

VaxCare

Chemotargets is a competitor specializing in computational systems for drug discovery and development.

Chemotargets

Histogen is a competitor in the biotechnology sector, focusing on regenerative medicine and cell therapies.

Histogen

Spring Bank Pharmaceuticals is a competitor specializing in innovative small molecule pharmaceuticals.

Spring Bank Pharmaceuticals

Excision BioTherapeutics is a competitor in the field of gene editing and gene therapy.

Excision BioTherapeutics

Bright Peak is a competitor offering innovative solutions in the biotechnology sector.

Bright Peak

Neobrain is a competitor that provides AI-driven solutions for various industries.

Neobrain

Lightcast is a biotechnology company that specializes in AI-driven drug discovery and development. The company has established an Innovation Center in the United States to support the global expansion of its Luminary Early Access Program, which aims to democratize access to AI-driven drug discovery for researchers worldwide.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 9:22 AM	f1769dd9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	3445f057
crunchbase profile	general	Nov 22, 2024 9:29 AM	507ad2a1
li profile	general	May 16, 2024 9:22 AM	9fcc2836
translate crunchbase fundingrounds	general	Nov 22, 2024 2:01 PM	fdff5296
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BIO:LIGHTCAST

Lightcast